Considering a distinction for neoplasm, among the 100 MBC patients, 16 were carriers of germline PVs in BRCA2 and only one in BRCA1, whereas 80 were BRCA1/2-wild-type (Figure 1). Here, BRCA2 is linked to neoplasm.